Saliva tests, more effective in detecting the omicron variant
20 January 2022Call for proposal ERA-Net Neuron 2022
20 January 2022
1.200 people over 65 years of age participated in the study and its objective was to answer how long immunity lasts.
La administration of the third dose increases the number of antibodies against the coronavirus, both in people who have had the infection and in those who have not, and it is also effective for the omicron variant, according to the first results of a study by the Carlos III Institute.
At the press conference after the Interterritorial Council of the National Health System this Wednesday, the director of the research center, Cristóbal Belda, explained that 1.200 people over 65 years of age participated in the study and its goal was to answer how long vaccine-induced immunity lasts.
"Clearly, there is an increase in the number of antibodies that is generated in people after the third dose. This increase is common to people who have or have not had the infection. Therefore, the third dose is effective in increasing antibodies; It is also effective against omicron, increasing its effectiveness up to ten times compared to not administering the third dose," he added.
According to the study, that has been carried out over the last four months and that remains open, the increase in total antibodies after the third dose is up to twenty times more in those over 65 years of age.
Source: El Heraldo de Aragón
